Abstracts

CORRELATION OF RENAL BIOMARKERS AND TENOFOVIR AUC IN THE ION-4 STUDY COHORT

The ION-4 study assessed the safety and efficacy of ledipasvir/sofosubvir (LDV/SOF) for 12 weeks in patients with chronic HIV and HCV infections. Concomitant dosing of ledipasvir and tenofovir disoproxil fumarate (TDF) results in increased tenofovir (TFV) area under the curve (AUC). Retinol binding protein-4(RBP4) and β2-microglobulin(B2M) are currently the most reliable urinary biomarkers for detecting…

HEPATOCELLULAR CARCINOMA AFTER SVR WITH IFN-FREE REGIMENS IN HIV/HCV COINFECTION

The consecution of sustained virological response (SVR) is associated with a reduction in the risk of liver-related events, including hepatocellular carcinoma (HCC), and liver-related mortality in HIV/HCV-coinfected patients. However, HIV/HCV-coinfected patients who achieve SVR are still at risk of developing HCC. It is not known if the risk of developing HCC after SVR has been…

IDENTIFICATION OF HCV INTER-SUBTYPE RECOMBINANT STRAINS WITH BREAKPOINTS IN NS5A

Hepatitis C virus (HCV) is classified into seven major genotypes (GT) and numerous subtypes. HCV GT and subtype are associated with differences in clinical outcomes, response to treatment and epidemiology. A better understanding of recombination in HCV is of practical importance and evolutionary interest. Recombinant HCV strains were identified during routine drug resistance testing of…

SYNERGY BETWEEN COMBINATIONS OF ANTI-HCV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES

No single broadly-neutralizing monoclonal antibody (bNAb) effectively neutralizes all strains of hepatitis C virus (HCV). Therefore, induction of antibody responses that target multiple distinct epitopes may be needed for an effective vaccine. This vaccination strategy would be most effective if bNAbs interact synergistically, and less effective if bNAbs interact antagonistically. We hypothesized that bNAbs binding…

DETECTION AND CHARACTERIZATION OF CELLS EXPRESSING HIV RNA BY FLOW CYTOMETRY

Our current knowledge of HIV-infected cell populations is largely derived from flow cytometry studies using antibodies to p24- the HIV capsid protein and most abundantly expressed antigen. However, p24 is an imperfect marker of infected cells that requires artificial activation for its detection, especially when analyzing rare HIV+ cells from ART-treated individuals. Much less is…

INFLAMMASOME-REGULATED CYTOKINE IL-37 INHIBITS HIV-1 REPLICATION IN PRIMARY HUMAN CD4

Interleukin (IL)-37 is a recently characterized member of the IL-1 family of cytokines that regulate innate immune responses. Like other inflammasome-regulated cytokines it’s maturation and release is dependent on inflammasome activity and caspase-1 activation. HIV-1 infected individuals have elevated levels of circulating inflammasome cytokines. We assessed the effects of inflammasome-regulated cytokines on HIV-1 replication in…

BCA2 INTERFERES WITH HIV-1 TRANSCRIPTION BY ENHANCING THE SUMOYLATION OF IΚBΑ

BCA2 (breast cancer-associated gene 2) is an E3 ubiquitin ligase that serves as a co-factor in the restriction imposed by Tetherin on HIV-1. We recently demonstrated that BCA2 also has Tetherin-independent activity. Particularly, BCA2 targets HIV-1 Gag for lysosomal degradation, impairing virus assembly. Since many antiviral factors modulate the NF-κB pathway, we sought to explore…

RHO FAMILY GTPASES ENHANCE HIV-1 INFECTION

HIV-1 co-opts host cellular machinery to complete its replication cycle, including cytoskeletal components for intracellular trafficking, nucleoproteins for pre-integration complex (PIC) import, and the ESCRT pathway for assembly and budding. It is widely recognized that cellular post-translational modifications (PTMs) regulate protein activity within cells; however, little is known about how PTMs influence HIV replication. Previously,…

SEMEN FACTORS ASSOCIATED WITH SEMEN VIRAL LOAD AND INFECTION-ENHANCING ACTIVITY

We have previously reported that seminal plasma from HIV negative men can markedly enhance HIV infection of permissive cells, and that this activity is positively associated with endogenous concentrations of SEM1(86-107), a peptide derived from a protein produced by the seminal vesicles. In vitro, SEM1(86-107) polymerizes to form amyloid fibrils that enhance HIV infection, and…